Ben Lamm

Edge of Extinction: Pioneering Texas Biotech Colossal and BioRescue Race to Save the Northern White Rhino Species

With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE
Ben Lamm Hypergiant
The Last Word: Dallas Serial Entrepreneur Ben Lamm Exits Another Company
by | Aug 22, 2023
Dating apps can be a great way to find romance. But increasingly, according to the Wall Street Journal, users are finding something else instead: business come-ons from tech recruiters, networkers, children's book authors, and more.
MORE
Meet the North Texas Cos. on the 2023 TIME100 Most Influential List
by | Jun 21, 2023
Featuring "a diverse group of businesses helping chart an essential path forward," the TIME100 Most Influential Companies list features five companies that are either headquartered in North Texas or have a strong presence here. See who they are—and what they're doing to disrupt the status quo and innovate for the future.
MORE
Ben Lamm Hypergiant

Hypergiant Awarded Over $16M from U.S. Air Force for Cloud-Based Command and Control UX

by | May 5, 2023
Hypergiant Galactic Systems Founder and Board Member Ben Lamm—who's also the co-founder and CEO of Texas-based Colossal Biosciences—tweeted out six rocket emojis to congratulate the Hypergiant team.
MORE
Here Are the Winners of The Innovation Awards 2023
by | Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District. Here's a full list of winners and finalists.
MORE
Meet the Finalists: The Innovation Awards 2023, Presented by Dallas Innovates and D CEO
by | Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas. Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE

The Last Word: Colossal’s Ben Lamm on Seeing His Startup Fuel a ‘Jeopardy’ Answer

by | Oct 3, 2022
In August, Colossal Biosciences announced it is working to "de-extinct" the Tasmanian tiger with the help of an Australian university and “marsupial biobanking.” It didn't take long for the TV show "Jeopardy" to notice—and work it into an answer.
MORE
Follow the Money: Book.io Aims to Put E-Books on the Blockchain with New Funding, Tech Startup Kalpa Aims to Raise $1M, and More
by | Sep 30, 2022
In this week’s North Texas deal flow, you’ll also find news about crowdfunding platform Harvest Return landing $2.5M; Supply’s acquisition by Foundry Brands; Moss Adams acquiring local CPA firm Kurtz & Company P.C.; Tri Global Energy being acquired for $270M by Canada's Enbridge; and more.
MORE
Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’
by | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.

The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE

Mammoth Project: Dallas’ Colossal Raises $60M to Advance Genetic Engineering and ‘De-Extinction’ Technologies

Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid. With a total raise of $75 million to date, the startup aims to have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE
Dallas’ Ben Lamm and Harvard’s Dr. George Church Plan to ‘De-Extinct’ the Woolly Mammoth With Their Colossal New Startup
by | Sep 13, 2021
It's not "Jurassic Park," but it's almost as amazing. Hypergiant founder Ben Lamm is launching a new biosciences and genetics startup—Colossal—with $15 million in private funding. The goal: Use genomics to "de-extinct" the woolly mammoth and re-wild it on the Arctic tundra. Lamm's co-founder, Harvard geneticist Dr. George Church, says this "grand vision" could lead to big opportunities in conservation, biodiversity, carbon sequestration, and more.
MORE
Hypergiant Industries Names Enterprise Tech Expert as CEO; Founder Ben Lamm Moves to Vice Chairman
by | May 18, 2021
Software executive Mike Betzer will lead the next phase of Hypergiant's growth, including a rollout of the industry's first system that provides open AI integration for building AI models.

Founder Ben Lamm, who launched Hypergiant from stealth in 2018, will pursue "the most pressing issues of our lifetime": AI for good, climate change, and the positive impact of technology. "This is where the world needs my time and attention," he says.
MORE